Breaking News
February 23, 2018 - Tobacco Kills, No Matter How It’s Smoked: Study
February 23, 2018 - Q&A: Avindra Nath, MD | Medpage Today
February 23, 2018 - Adherence to sleep apnea treatment affects risk of hospital readmission
February 23, 2018 - Zika virus could be alternative for treatment of aggressive brain cancer
February 23, 2018 - Carbon monoxide enhances efficacy of antibiotic against stomach infection
February 23, 2018 - MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage
February 23, 2018 - Postnova AF2000 system offers reliable characterization of trace metal colloid distribution in the environment
February 23, 2018 - Pioneering study may pave way for effective painkillers to treat neuropathic pain
February 23, 2018 - Research opens up new avenue to minimize risks of transplants
February 22, 2018 - Cabozantinib Active in Advanced Thyroid Cancer
February 22, 2018 - Polluted air may pollute our morality
February 22, 2018 - New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment
February 22, 2018 - Bank loans signed in the hospital leave patients vulnerable
February 22, 2018 - Researchers identify new nanostructure inside sperm tails
February 22, 2018 - Catheter-based procedure increases treatment options for mitral valve disease
February 22, 2018 - Sage Therapeutics Receives FDA Breakthrough Therapy Designation for SAGE-217 for the Treatment of Major Depressive Disorder
February 22, 2018 - Larger Endocarditis Vegetations More Likely to Embolize, Kill
February 22, 2018 - Parenting behavior in adoptive families
February 22, 2018 - Researchers discover new weakness in sleeping sickness parasites
February 22, 2018 - Research project aims to find new ways to identify and treat most aggressive brain cancers
February 22, 2018 - Researchers explore how people with Alzheimer’s disease use end-of-life medical services
February 22, 2018 - Stroke survivors and carers feel marginalized due to lack of support from primary care
February 22, 2018 - Neuroscientists discover novel mechanism of action behind schizophrenia
February 22, 2018 - After shooting, ‘honor how kids want to deal with their feelings’
February 22, 2018 - U.S., EU and Japan Health Authorities Accept Regulatory Submissions For Review Of Pfizer’s Third-generation ALK Inhibitor Lorlatinib
February 22, 2018 - At-Home Genetic Test Might Change Medicine
February 22, 2018 - Many second hand plastic toys could pose a risk to children’s health, study suggests
February 22, 2018 - Study shows that two different brain systems cooperate during learning
February 22, 2018 - Liquefied brain tissue after stroke may harm surviving brain, UA study finds
February 22, 2018 - New intervention improves communication behaviors in couples affected by dementia
February 22, 2018 - Clinical trial shows safety of promising TSRI stroke drug
February 22, 2018 - Researchers discover new interaction mechanism of unstructured proteins
February 22, 2018 - A Patient’s Journey: Can I Kill the Glucose Monster?
February 22, 2018 - The Problem That Piles Up
February 22, 2018 - Kids can roll up their sleeves—again—for mumps protection
February 22, 2018 - Scientists find significant amounts of toxic metals in e-cigarette vapors
February 22, 2018 - 3D Signatures reports positive results of new Telo-HL test for Hodgkin’s lymphoma
February 22, 2018 - Scientists reveal development of improved medicine to fight addiction
February 22, 2018 - USC-led researchers release dataset of brain scans from stroke patients
February 22, 2018 - Antibiotic-producing bacterium releases more metabolites than assumed
February 22, 2018 - Flu Season Shows First Signs of Slowing
February 22, 2018 - Nonstick Chemicals May Disrupt Metabolic Function in Women
February 22, 2018 - Calcium may play a role in the development of Parkinson’s disease
February 22, 2018 - Scientists visualize insulin receptor activation for the first time
February 22, 2018 - UC San Diego Health now offers new treatment option for people with refractory epilepsy
February 22, 2018 - First African child vaccinated with new typhoid conjugate vaccine
February 22, 2018 - BetterYou named as ‘Most Innovative Brand’ at FGB Awards 2018
February 22, 2018 - Assaults Among Young People Fall to Lowest Rate in 15 Years
February 22, 2018 - What do you know about Parkinson’s disease?
February 22, 2018 - Researchers discover five new genetic changes that may increase pancreatic cancer risk
February 22, 2018 - Gout medication may help improve heart function in adult patients
February 22, 2018 - Bioactive compound limits collateral damage in the kidneys after heart attack
February 22, 2018 - Study reveals HCT as effective treatment for NHL patients regardless of age
February 22, 2018 - Father’s age can affect offspring lifespan, mice study shows
February 22, 2018 - Opiant Pharmaceuticals Announces Publication of New Pre-Clinical Data Supporting Potential of OPNT005 as a Heroin Vaccine
February 22, 2018 - Make the Diagnosis: Strange Rash Surfaces
February 22, 2018 - Isolated sulfite oxidase deficiency – Genetics Home Reference
February 22, 2018 - Scientists identify weight loss ripple effect
February 22, 2018 - Smoking at record lows in New York
February 22, 2018 - Scientists pinpoint fertility hormone that could support early pregnancy
February 22, 2018 - Aggressive cancer stem cells can now be isolated successfully in a scientific breakthrough
February 22, 2018 - Researchers find high risk of suicide among unaccompanied refugee minors
February 22, 2018 - Protein levels linked to posture and gait problems in Parkinson’s
February 22, 2018 - Biomedical engineers create 3D hydrogel scaffolds  to transform cells into muscle
February 22, 2018 - Study employs novel approach to uncover new biomarker for CHD
February 22, 2018 - Study finds strong connection between midwifery and birth outcomes
February 22, 2018 - Verastem Submits NDA to FDA for Duvelisib for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
February 22, 2018 - Low BP Associated With Risk in HFpEF
February 22, 2018 - More U.S. women obese before pregnancy, experts sound the alarm
February 22, 2018 - Study aims to examine effects of PTSD symptoms in police officers
February 22, 2018 - Study reveals increased disease risk after early heart surgery
February 22, 2018 - Women with Type 1 diabetes come across unique challenges
February 22, 2018 - Researchers target abnormal epigenetic mechanisms involved in childhood cancers
February 22, 2018 - Wine polyphenols may be good for oral health
February 22, 2018 - Moderate and severe exacerbations associated with decline in physical activity of COPD patients
February 22, 2018 - FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions
February 22, 2018 - Morning Break: NSCLC Approval; School Nurses; ‘Human-Sheep Hybrids’?
February 22, 2018 - Penn study sheds new light on immune cell identity
February 22, 2018 - From a novel support group to a book, learning from seven widowed fathers
February 22, 2018 - Researcher makes breakthrough discovery in process of fear relapse
Researchers solve 3D structure of primary optogenetic tool

Researchers solve 3D structure of primary optogenetic tool

image_pdfDownload PDFimage_print

An international team of researchers from the Moscow Institute of Physics and Technology, Forschungszentrum Jülich, the European Synchrotron Radiation Facility, the Institut de Biologie Structurale, and the Max Planck Institute of Biophysics has determined the 3-D structure of channelrhodopsin 2, a membrane protein widely used in optogenetics to control nerve cells with light.

Optogenetics is a relatively new technique that involves the use of light to manipulate nerve and muscle cells in a living organism. Similar approaches are used to partially reverse the loss of hearing and eyesight and control muscle contractions.

In addition, the methods of optogenetics are used to study the properties of natural neuron networks, which are responsible for emotion, decision-making, and other complex processes in living organisms. Optogenetics was Nature‘s “Method of the Year 2010,” as well as being named among Science‘s “Breakthroughs of 2010 and Insights of the Decade.”

Channelrhodopsin 2, or ChR2, is a major optogenetic tool. It is a light-sensitive protein, which was originally extracted in 2003 from a green alga called Chlamydomonas reinhardtii. Scientists can insert ChR2 into the membrane of a living cell to control it. When illuminated, this protein allows positively charged ions to pass into the cell through the cell membrane. In a nerve cell, this depolarizes the membrane, mimicking the effect of a nerve impulse and causing this particular neuron to fire.

Because ChR2 works fast and is relatively harmless to cells, it is the current go-to solution for nerve cell activation. A range of artificially induced mutations are available for altering the protein’s properties. For example, it is possible to increase the current it generates or alter the wavelength of light it responds to. Such modifications enable experimenters to work with proteins tailored to their needs. Researchers can even combine several protein variants for a distinct response at various wavelengths of light.

Most of the mutations used to modify the properties of ChR2 have so far been introduced more or less at random — either via directed evolution or based on the data on known protein structures. The closest we’ve ever gotten to a realistic ChR2 structure is an odd combination called C1C2, 70 percent of which is based ChR1, a related protein, with the rest based on the actual ChR2. This mixed structure cannot account for all properties of the protein. As a result, the mutations predicted by this model are not quite realistic and therefore are of limited interest to optogenetics.

To reveal the structure of ChR2, the authors of the study reported in this story used an analytical technique called X-ray diffraction, which only works with samples in the form of a crystal. These were obtained by the researchers via in meso crystallization. That is to say, the protein crystals were grown in the so-called cubic lipid mesophase — a medium that allows proteins to move freely, without leaving the membrane. To determine protein structures, their crystals were irradiated with X-rays at a wavelength of about 1 angstrom, which is slightly less than the length of the bonds between the atoms in the protein. In X-ray crystallography, structures are derived by analyzing how radiation is scattered by a sample.

“Attempts to solve the structure of ChR2 go right back to the time of its discovery in 2003. But despite the efforts of numerous research groups from across the world, the structure of the protein in its natural state has remained unknown,” says Valentin Borshchevskiy, one of the authors of the paper and deputy head of the Laboratory for Advanced Studies of Membrane Proteins at MIPT. “Now that we have the structure, meaningful mutations can be introduced into the protein to adjust its properties to the requirements of a specific experiment. Not knowing the structure, we had to tediously work out the useful mutations by trial and error or make do with the data on related proteins.”

Source:

https://mipt.ru/english/news/structure_of_primary_optogenetic_tool_revealed

Tagged with:

About author

Related Articles